CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+9.06%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.6B
AUM Growth
+$14.6B
(+22%)
Cap. Flow
+$971M
Cap. Flow
% of AUM
6.65%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
968
New
130
Increased
365
Reduced
334
Closed
74
Top Buys
| 1 |
Microsoft
MSFT
|
$144M |
| 2 |
Royal Bank of Canada
RY
|
$123M |
| 3 |
Agilent Technologies
A
|
$78.5M |
| 4 |
UnitedHealth
UNH
|
$71.8M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$70.8M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$92.6M |
| 2 |
Amgen
AMGN
|
$87.9M |
| 3 |
Allstate
ALL
|
$52.7M |
| 4 |
PayPal
PYPL
|
$47.9M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
$47.4M |
Sector Composition
| 1 | Healthcare | 33.43% |
| 2 | Technology | 23.21% |
| 3 | Consumer Discretionary | 9.15% |
| 4 | Financials | 8.64% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Cenovus Energy
CVE
$29.9B
| – | – |
-12,886
| Closed | -$75K |
|
877
Cemex
CX
$13.2B
| – | – |
-76,375
| Closed | -$377K |
|
878
Enanta Pharmaceuticals
ENTA
$180M
| – | – |
-178,941
| Closed | -$7.24M |
|
879
EPAM Systems
EPAM
$9.82B
| – | – |
-25,300
| Closed | -$8.71M |
|
880
Equitable Holdings
EQH
$16B
| – | – |
-12,310
| Closed | -$303K |
|
881
Fortune Brands Innovations
FBIN
$7.02B
| – | – |
-3,707
| Closed | -$305K |
|
882
F5
FFIV
$18B
| – | – |
-84,236
| Closed | -$14.2M |
|
883
Fair Isaac
FICO
$36.5B
| – | – |
-16,389
| Closed | -$8.05M |
|
884
Amicus Therapeutics
FOLD
$2.34B
| – | – |
-615,124
| Closed | -$13.6M |
|
885
First Solar
FSLR
$20.9B
| – | – |
-30,405
| Closed | -$2.89M |
|
886
Immunovant
IMVT
$2.56B
| – | – |
-181,749
| Closed | -$8.06M |
|
887
KB Financial Group
KB
$28.6B
| – | – |
-6,776
| Closed | -$258K |
|
888
Kezar Life Sciences
KZR
$28.9M
| – | – |
-584,956
| Closed | -$2.93M |
|
889
Mizuho Financial
MFG
$82.2B
| – | – |
-18
| Closed | – |
|
890
Mitsubishi UFJ Financial
MUFG
$174B
| – | – |
-230
| Closed | -$1K |
|
891
Nektar Therapeutics
NKTR
$568M
| – | – |
-306,085
| Closed | -$5M |
|
892
Nkarta
NKTX
$151M
| $0 | ﹤0.01% |
4
-67,142
| -100% | – |
|
893
POSCO
PKX
$15.6B
| – | – |
-3,720
| Closed | -$223K |
|
894
Rocket Pharmaceuticals
RCKT
$354M
| – | – |
-128,749
| Closed | -$6.78M |
|
895
Arcus Biosciences
RCUS
$1.13B
| – | – |
-408,991
| Closed | -$10.2M |
|
896
Reinsurance Group of America
RGA
$12.9B
| – | – |
-6,648
| Closed | -$740K |
|
897
Rogers Corp
ROG
$1.42B
| – | – |
-1,406
| Closed | -$1.43M |
|
898
RTX Corp
RTX
$212B
| – | – |
-3,250
| Closed | -$222K |
|
899
Tanger
SKT
$3.87B
| – | – |
-14,000
| Closed | -$134K |
|
900
Syndax Pharmaceuticals
SNDX
$1.41B
| – | – |
-25,671
| Closed | -$548K |
|